Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

NCT03073967 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

HSV Infection

Interventions

DRUG: Pritelivir
DRUG: Investigator's choice

Sponsor

AiCuris Anti-infective Cures AG

Collaborators

[object Object]